The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Mifegyne 600 mg tablets


Main Information

Trade NameMifegyne 600 mg tablets
Active SubstancesMifepristone
Dosage FormTablet
Licence HolderEXELGYN
Licence NumberPA22946/001/002

Group Information

ATC CodeG03XB01 mifepristone


License statusAuthorised
Licence Issued30/11/2018
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceFor termination of pregnancy, this medicine can only be prescribed and administered in accordance with national law.
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back